Corrigendum: Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury

Affiliations

¹ Department of Neurosurgery, CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea.
² Department of Biomedical Science, CHA University, Seongnam-si, South Korea.
³ Department of Neurosurgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea.
⁴ Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

Published Erratum

Min-Jae Jo et al. Front Pharmacol. 2018.

. 2018 Aug 30:9:949.

doi: 10.3389/fphar.2018.00949. eCollection 2018.

¹ Department of Neurosurgery, CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea.
² Department of Biomedical Science, CHA University, Seongnam-si, South Korea.
³ Department of Neurosurgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea.
⁴ Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2018.00445.].

Keywords: M2 polarization; anti-inflammation; neuroprotection; spinal cord injury; α-asarone.

Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury.
Jo MJ, Kumar H, Joshi HP, Choi H, Ko WK, Kim JM, Hwang SSS, Park SY, Sohn S, Bello AB, Kim KT, Lee SH, Zeng X, Han I. Jo MJ, et al. Front Pharmacol. 2018 May 7;9:445. doi: 10.3389/fphar.2018.00445. eCollection 2018. Front Pharmacol. 2018. PMID: 29867457 Free PMC article.